![Scott Dreyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Dreyer
Corporate Officer/Principal bei
COLLEGIUM PHARMACEUTICAL, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Scott Dreyer is Chief Commercial Officer & Executive VP at Collegium Pharmaceutical, Inc. since 2018.
Formerly, Mr. Dreyer was Vice President-US Hospital & Oncology Sales at Merck & Co., Inc. from 1994 to 2013, Chief Marketing Officer & Vice President at Biogen, Inc. from 2014 to 2016, and Senior VP-Marketing & Commercial Operations at The Medicines Co. from 2016 to 2017.
Mr. Dreyer completed an undergraduate degree at the University of Messiah in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.03.2026 | 71.770 ( 0,22 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Scott Dreyer
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 10.07.2018 |
Ehemalige bekannte Positionen von Scott Dreyer
| Unternehmen | Position | Ende |
|---|---|---|
| THE MEDICINES COMPANY | Vertrieb & Marketing | 01.12.2017 |
| BIOGEN INC. | Vertrieb & Marketing | 01.09.2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Scott Dreyer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Messiah
 University of Messiah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
